The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.
While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.
The global Whole Exome Sequencing market was valued at US$ 296 million in 2023 and is anticipated to reach US$ 635.7 million by 2030, witnessing a CAGR of 11.4% during the forecast period 2024-2030.
The major players in global Whole Exome Sequencing market include Illumina, Thermofisher, Roche, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Illumina TruSeq Exome and Roche Nimblegen SeqCap are main types, with a share about 55%. Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.
This report aims to provide a comprehensive presentation of the global market for Whole Exome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Exome Sequencing.
Report Scope
The Whole Exome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Whole Exome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whole Exome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company (Partial List)
- Illumina
- Thermo Fisher
- Roche
- Angilent
- Eurofins
- Sengenics
- Ambry
- Macrogen
- BGI
- Novo Gene
Segment by Type
- Agilent HaloPlex
- Agilent SureSelect
- Agilent SureSelect QXT
- Illumina TruSeq Exome
- Roche Nimblegen SeqCap
- MYcroarray MYbaits
Segment by Application
- Correlation Research of Normal Human
- Mendelian Disease and Rare Syndrome Gene Discovery
- The Research of Complex Diseases
- Mouse Exome Sequencing
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Whole Exome Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Whole Exome Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Agilent HaloPlex
1.2.3 Agilent SureSelect
1.2.4 Agilent SureSelect QXT
1.2.5 Illumina TruSeq Exome
1.2.6 Roche Nimblegen SeqCap
1.2.7 MYcroarray MYbaits
1.3 Market by Application
1.3.1 Global Whole Exome Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Correlation Research of Normal Human
1.3.3 Mendelian Disease and Rare Syndrome Gene Discovery
1.3.4 The Research of Complex Diseases
1.3.5 Mouse Exome Sequencing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Exome Sequencing Market Perspective (2019-2030)
2.2 Whole Exome Sequencing Growth Trends by Region
2.2.1 Global Whole Exome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Whole Exome Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Whole Exome Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Whole Exome Sequencing Market Dynamics
2.3.1 Whole Exome Sequencing Industry Trends
2.3.2 Whole Exome Sequencing Market Drivers
2.3.3 Whole Exome Sequencing Market Challenges
2.3.4 Whole Exome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Exome Sequencing Players by Revenue
3.1.1 Global Top Whole Exome Sequencing Players by Revenue (2019-2024)
3.1.2 Global Whole Exome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Whole Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Whole Exome Sequencing Revenue
3.4 Global Whole Exome Sequencing Market Concentration Ratio
3.4.1 Global Whole Exome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Exome Sequencing Revenue in 2023
3.5 Whole Exome Sequencing Key Players Head office and Area Served
3.6 Key Players Whole Exome Sequencing Product Solution and Service
3.7 Date of Enter into Whole Exome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Exome Sequencing Breakdown Data by Type
4.1 Global Whole Exome Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Whole Exome Sequencing Forecasted Market Size by Type (2025-2030)
5 Whole Exome Sequencing Breakdown Data by Application
5.1 Global Whole Exome Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Whole Exome Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Whole Exome Sequencing Market Size (2019-2030)
6.2 North America Whole Exome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Whole Exome Sequencing Market Size by Country (2019-2024)
6.4 North America Whole Exome Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Whole Exome Sequencing Market Size (2019-2030)
7.2 Europe Whole Exome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Whole Exome Sequencing Market Size by Country (2019-2024)
7.4 Europe Whole Exome Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Whole Exome Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Whole Exome Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Whole Exome Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Whole Exome Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Whole Exome Sequencing Market Size (2019-2030)
9.2 Latin America Whole Exome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Whole Exome Sequencing Market Size by Country (2019-2024)
9.4 Latin America Whole Exome Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Exome Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Whole Exome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Whole Exome Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Whole Exome Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Whole Exome Sequencing Introduction
11.1.4 Illumina Revenue in Whole Exome Sequencing Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Whole Exome Sequencing Introduction
11.2.4 Thermo Fisher Revenue in Whole Exome Sequencing Business (2019-2024)
11.2.5 Thermo Fisher Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Whole Exome Sequencing Introduction
11.3.4 Roche Revenue in Whole Exome Sequencing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Angilent
11.4.1 Angilent Company Detail
11.4.2 Angilent Business Overview
11.4.3 Angilent Whole Exome Sequencing Introduction
11.4.4 Angilent Revenue in Whole Exome Sequencing Business (2019-2024)
11.4.5 Angilent Recent Development
11.5 Eurofins
11.5.1 Eurofins Company Detail
11.5.2 Eurofins Business Overview
11.5.3 Eurofins Whole Exome Sequencing Introduction
11.5.4 Eurofins Revenue in Whole Exome Sequencing Business (2019-2024)
11.5.5 Eurofins Recent Development
11.6 Sengenics
11.6.1 Sengenics Company Detail
11.6.2 Sengenics Business Overview
11.6.3 Sengenics Whole Exome Sequencing Introduction
11.6.4 Sengenics Revenue in Whole Exome Sequencing Business (2019-2024)
11.6.5 Sengenics Recent Development
11.7 Ambry
11.7.1 Ambry Company Detail
11.7.2 Ambry Business Overview
11.7.3 Ambry Whole Exome Sequencing Introduction
11.7.4 Ambry Revenue in Whole Exome Sequencing Business (2019-2024)
11.7.5 Ambry Recent Development
11.8 Macrogen
11.8.1 Macrogen Company Detail
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Whole Exome Sequencing Introduction
11.8.4 Macrogen Revenue in Whole Exome Sequencing Business (2019-2024)
11.8.5 Macrogen Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Whole Exome Sequencing Introduction
11.9.4 BGI Revenue in Whole Exome Sequencing Business (2019-2024)
11.9.5 BGI Recent Development
11.10 Novo Gene
11.10.1 Novo Gene Company Detail
11.10.2 Novo Gene Business Overview
11.10.3 Novo Gene Whole Exome Sequencing Introduction
11.10.4 Novo Gene Revenue in Whole Exome Sequencing Business (2019-2024)
11.10.5 Novo Gene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
